Ngs Based Rna Seq Market Scope And Analysis

Report Code : TIPBT00002556
Category : Life Sciences

No. of Pages : 150

Buy Now

NGS Based RNA Seq Market Scope and Analysis Report by 2031

Buy Now

NGS Based RNA Seq Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 3.25 Billion
Market Size by 2031	US$ 13.35 Billion
Global CAGR (2023 - 2031)	9.32%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Product & Services Sample Preparation Sequencing Services Sequencing Platform & Consumables and Data Analysis Storage & Management By Technology Sequencing Synthesis Nanopore Sequencing Ion Semiconductor Sequencing and Single Molecule Real Time Sequencing By Application Diagnostics Drug Discovery Precision Medicine By End User Biotechnology & Pharmaceutical Companies Hospitals & Clinics Research Centers and Academic & Government Institutes
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Illumina Inc PerkinElmer Inc F Hoffmann La Roche Ltd QIAGEN N V Agilent Technologies Inc Thermo Fisher Scientific Inc Oxford Nanopore Technologies Pacific Biosciences of California Inc BGI Eurofins Scientific

NGS Based RNA Seq Market News and Recent Developments

The NGS based RNA seq market is evaluated by gathering qualitative and quantitative data from primary and secondary research, which includes essential corporate publications, association data, and databases. A few of the developments in the NGS based RNA seq market are listed below:

Twist Bioscience launched a portfolio of RNA sequencing tools. The portfolio includes Twist RNA Exome, Twist RNA Library Prep Kit, and the Twist Ribosomal RNA (rRNA) and Hemoglobin (Globin) Depletion Kit, as well as custom target enrichment capabilities for RNA and whole transcriptome sequencing. Twist's RNA sequencing portfolio is built on its established NGS capabilities in genomic sequencing and methylation detection. It also expands into gene expression analysis, opening a new and significant market for the company. (Source: Twist Bioscience, Press Release, 2023)
Illumina Inc. launched its DRAGEN v4. 0, an accurate and comprehensive secondary analysis platform. The product enables single-cell resolution profiling of chromatin accessibility. It can be run with DRAGEN’s single-cell RNA-seq pipeline as part of the single-cell multiomics pipeline. (Source: Illumina Inc, Press Release, 2022)

NGS Based RNA Seq Market Report Coverage and Deliverables

The “NGS based RNA seq Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

NGS based RNA seq market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
NGS based RNA seq market trends, as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
NGS based RNA seq market analysis covering key market trends, global and regional framework, significant players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the NGS based RNA seq market
Detailed company profiles